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Abstract
Background:  Tropheryma whipplei, the agent of Whipple's disease (WD), has been recently
isolated and the genomes of two isolates have been fully sequenced. Previous diagnosis tools for
the diagnosis of the disease used sequence analysis of the 16S rRNA gene. Using this target gene,
the high percentage of detection of the bacterium in saliva of healthy people was in contrast to the
negative results obtained with specific target genes. The aim of our study was to compare
previously published primers targeting the 16S rRNA gene to real-time PCR with Taqman* probes
targeting specific repeat genes only found in the genome of T. whipplei in a series of 57 saliva from
healthy people.
Results: Although the specific real-time PCR assays with both primers and probes were negative
for all the samples, 13 out of 57 samples were positive with different primers previously reported
targeting the 16S rRNA gene. Among the positive samples, 8 yielded a 231-bp sequence that was
99.1% identical to that of Actinomyces odontolyticus, 2 yielded a 226-bp that was 99.6% identical to
that of A. turicensis, and 3 yielded a 160-bp sequence that was 98.5% identical to that of
Capnocytophaga gingivalis. We found that the C. gingivalis and A. odontolyticus 16S rRNA sequences
obtained in our study share more than 80% homology with the corresponding 16S rRNA sequences
of the T. whipplei genomes especially at 5' and 3' end.
Conclusion: Asymptomatic carriers of T. whipplei in saliva may exist but their prevalence is much
lower than those previously reported. Testing the specificity of designed primers is critical to avoid
false positive detection of T. whipplei. In atypical case we recommend to test two different specific
target genes before concluding.
Background
Tropheryma whipplei, the agent of the Whipple's disease
(WD), has been recently isolated and cultured [1] and is
classified within the Actinomycetes clade [2]. On the basis
of sequence analysis of the 16S rRNA gene, several diag-
nostic PCR assays targeting various parts of this gene have
been reported and PCR has become an important diag-
nostic tool [2]. One of the important limits of PCR target-
ing the 16S rRNA gene is its specificity. Indeed, positive
PCR results have been found in specimens from people
without the classic clinical or histological features of WD.
In one series, T. whipplei DNA was apparently detected in
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25 out of 38 waste-water samples obtained from five dif-
ferent sewage treatment plants in Southwest Germany [3],
and in 13.3% of either duodenal biopsies specimens or
gastric juice specimens from 105 patients with no clinical
signs of WD [4]. Similarly, in a random sample of 40
healthy people, Street et al. found that 35% had T. whipplei
DNA detected in their saliva [5]. Dutly et al. have also
reported the presence of T. whipplei DNA in saliva of
healthy people [6]. All these data were obtained using
primers targeting a part of the 16S rRNA gene. In contrast,
using specific primers of the 16S-23S ribosomal DNA
intergenic spacer (ITS) [7] and primers targeting a 650-bp
fragment of the β-subunit of the RNA polymerase gene
(rpoB) [8], 100 saliva specimens from people without sus-
picion of WD failed to yield a significant PCR product sig-
nal [9]. Maiwald et al. also reported that T. whipplei occurs
only rarely in intestinal mucosa that lacks histopathologic
evidence of WD [10]. These conflicting and confusing
data emphasize the need for additional information on
the prevalence of T. whipplei in healthy people, especially
in saliva. For this purpose we have compared in this study
the use of specific target genes repeated sequences present
in seven copies in the genome of T. whipplei [11] in a real-
time PCR with Taqman* probes, with the previously pub-
lished primers targeting the 16S rRNA gene [5,6,12] in
saliva from healthy people.
Results
The sensitivity of our real-time PCR assay was of 1 DNA
copy of standard control DNA. Specificity was verified
using DNA extracted from 40 bacterial strains as previ-
ously described [11]; none of the DNA yield a positive sig-
nal for the two sets of primers and probes. Although the
LightCycler PCR results with both primer pairs and probes
were negative for all the saliva, 10 and 3 out of 57 samples
were positive with the primers used by Dutly et al. and
Ramzan et al. [6,12] and from Street et al [5], respectively.
Among the 10 positive samples using the primers of Dutly
et al., 8 yielded a 231 bp sequence that was 99.1% identi-
cal to that of Actinomyces odontolyticus (Genbank accession
number AJ234047) and 2 yielded a 226 bp that was
99.6% identical to that of Actinomyces turicensis (Genbank
accession number X78720). The 3 sequences obtained
using the primers from Street et al. yielded a 160 bp
sequence that was 98.5% identical to that of Capnocy-
tophaga gingivalis (Genbank accession number X67608).
The 16S rRNA sequences of the two available genomes of
T. whipplei (Strain Twist, Genbank accession number NC
004572 and strain TW08/27, Genbank accession number
00 4551) were retrieved from the KEGG website [13] and
were used for sequence alignments using the ClustalW
software [14] with our two original sequences of A. odon-
tolyticus (Figure 1) and C. gingivalis (Figure 2). The C. gin-
givalis 16S rRNA sequence shares 80.6% homology (129/
160 bp) and the A. odontolyticus 16S rRNA sequence shares
91.8% homology (212/231 bp) with the corresponding
16S rRNA sequences of the T. whipplei genomes (Figures 1
and 2).
Discussion
In this study, using the same PCR protocols previously
used for the detection of T. whipplei, the sequences
obtained with primers of the 16S rRNA gene were in all
cases false positive PCR results with sequences similar to
that of bacteria of the oral cavity and not with T. whipplei.
A better sensitivity and specificity using repeated
sequences instead of the 16S rRNA gene has also been
reported in other bacteria such as Coxiella burnetii [15].
Thus we believe that such high prevalence of T. whipplei
DNA described in the saliva of healthy people reported
using less specific PCR-based methods targeting the 16S
rRNA gene are likely due to false positive amplifications of
bacteria of the oral cavity. Therefore positive PCR results
using the 16S rRNA gene should be interpreted cautiously
and sequencing should be the rule. For example, in the
study of Street et al., only 6 positive PCR products of 14
patients were sequenced [5] yielding a 100% homology
with the 16S rRNA sequence of T. whipplei. Since the
remaining positive samples were not sequenced it is pos-
sible that other bacteria found in the oral cavity such as
Actinomyces spp. or C. gingivalis were the cause of the false
positive results. This is particularly important when com-
paring the sequences in our study with the 16S rRNA
sequences of T. whipplei with a high percentage of homol-
ogy of the sequences, especially at both the 5' and 3' ends
(Figures 1 and 2). Since we have started to perform the
diagnosis of WD in our laboratory, T. whipplei DNA has
been demonstrated using our PCR assays in saliva from 4
out of 620 (0.6%) patients without WD [9,11,16]. Zinker-
nagel et al have demonstrated that the subgingival plaque
may serve as a natural habitat of T. whipplei [17]. In this
study, using a real-time quantitative PCR assay, authors
found also that all samples from saliva were negative [17].
Conclusion
Asymptomatic carriers of T. whipplei in saliva may exist
but their prevalence is much lower than those previously
reported. Testing the specificity of designed primers is crit-
ical to avoid false positive detection of T. whipplei. In atyp-
ical case we recommend to test two different specific target
genes before concluding.
Methods
Approximately 1 ml of saliva from consenting healthy
people working in our institution was collected anony-
mously and aseptically in sterile tubes during our
monthly laboratory meeting. These volunteers were from
diverse ethnic background, aged from about 20 to 60
years old and their dental status was not known. Experi-BMC Microbiology 2007, 7:48 http://www.biomedcentral.com/1471-2180/7/48
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mental research reported in this study has been approved
by the ethical committee of IFR48. DNA extraction was
performed on each sample as previously described [7,9].
PCR was performed using either primers and protocols
described by Street et al. [5] and Dutly et al. and Ehrbar et
al. [4,6] or two sets of primers and Taqman* probes tar-
geting specific repeated sequences from the genome of T.
whipplei  [11,18]. Primers TW27F (5'-TGTTTTGTACT-
GCTTGTAACAGGATCT-3') and TW182R (5'- TCCT-
GCTCTATCCCTCCTATCATC-3') and probe 27F-182R
(6FAM- AGAGATACATTTGTGTTAGTTGTTACA-TAMRA)
and primers TW342F (5'- AGATGATGGATCTGCTTTCT-
TATCTG-3') and TW492R (5'- AACCCTGTCCTGCAC-
CCC-3') and probe 342F-492R (6FAM-
TATGTGTGTTGGTTATATATGGG-TAMRA) were used in
this study that amplify a 155-bp and a 150-bp fragment of
Sequence alignments of the partial sequence of 16S rRNA gene of T. whipplei strain Twist, TW08/27 and A. odontolyticus ampli- fied from saliva of healthy people in this study using the primers from Dutly et al. and Ramzan et al. that are in bold and under- lined Figure 1
Sequence alignments of the partial sequence of 16S rRNA gene of T. whipplei strain Twist, TW08/27 and A. odontolyticus ampli-
fied from saliva of healthy people in this study using the primers from Dutly et al. and Ramzan et al. that are in bold and under-
lined.
Twist ATACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCA 1080
TW08/27 ATACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCA 1080
A_odontolyticus -----------TCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCA 49
 ************************************************
Twist ACGAGCGCAACCCTCGTCCTGTGTTGCCAGCGCGTAATGGCGGGGACTCACAGGAGACTG 1140
TW08/27 ACGAGCGCAACCCTCGTCCTGTGTTGCCAGCGCGTAATGGCGGGGACTCACAGGAGACTG 1140
A_odontolyticus ACGAGCGCAACCCTTGCCCTATGTTGCCAGCACGTGATGGTGGGGACTCGTGGGGGACTG 109
************** * *** ********** *** **** ********  ** *****
Twist CCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCTTCG-GTCTTG 1199
TW08/27 CCGGGGTCAACTCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCTTCG-GTCTTG 1199
A_odontolyticus CCGGGGTTAACTCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGTCTTG 169
******* ***************************************** *   ******
Twist GGCTTCACGCGTGCTACAATGGCTGGTACAGAGGGTTGCAATATCGCAAGGTGGAGCGAA 1259
TW08/27 GGCTTCACGCGTGCTACAATGGCTGGTACAGAGGGTTGCAATATCGCAAGGTGGAGCGAA 1259
A_odontolyticus GGCTTCACGCATGCTACAATGGTTGGTACAGAGGGTTGCGATATCGCAAGGTGGAGCGAA 229
********** *********** **************** ********************
Twist TCTCAAAAAGCCAGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAG 1319
TW08/27 TCTCAAAAAGCCAGTCTCAGTTCGGATTGGGGTCTGCAACTCGACCCCATGAAGTCGGAG 1319
A_odontolyticus TG---------------------------------------------------------- 231
*
Sequence alignments of the partial sequence of 16S rRNA gene of T. whipplei strain Twist, TW08/27 and C. gingivalis amplified  from saliva of healthy people in this study using the primers from Street et al. that are in bold and underlined Figure 2
Sequence alignments of the partial sequence of 16S rRNA gene of T. whipplei strain Twist, TW08/27 and C. gingivalis amplified 
from saliva of healthy people in this study using the primers from Street et al. that are in bold and underlined.
Twist CCTTACCAAGGCTTGATATATACCGGAAAGGCGTAGAGATACGCCCCCCGCAAGGTCGGT 1020
TW08/27 CCTTACCAAGGCTTGATATATACCGGAAAGGCGTAGAGATACGCCCCCCGCAAGGTCGGT 1020
C_gingivalis --------------------TACCGGAAAGGCGTAGAGATACGCCCTTCTTCGGACAGTT 40
**************************  * * * *
Twist ATACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCA 1080
TW08/27 ATACAGGTGGTGCACGGTTGTCGTCAGCTCGTGTCGTGAGATGTTGGGTTAAGTCCCGCA 1080
C_gingivalis TTCAAGGTGCTGCATGGTTGTCGTCAGCTCGTGCCGTGAGGTGTCAGGTTAAGTCCTATA 100
 * ***** **** ****************** ****** ***  ********** *
Twist ACGAGCGCAACCCTCGTCCTGTGTTGCCAGCGCGTAATGGCGGGGACTCACAGGAGACTG 1140
TW08/27 ACGAGCGCAACCCTCGTCCTGTGTTGCCAGCGCGTAATGGCGGGGACTCACAGGAGACTG 1140
C_gingivalis ACGAGCGCAACCCCTATTGTTAGTTACCAGCACGTAATGGCGGGGACTCACAGGAGACTG 160
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the repeat sequence of T. whipplei, respectively. The sensi-
tivity and specificity of our Taqman* PCR assay was deter-
mined using tenfold dilutions of a standard suspension of
106 T. whipplei strain Marseille-Twist and DNA extracted
from 40 bacterial strains as previously described [11].
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